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Background:  Multiple studies have confirmed that waist circumference (WC) and waist/hip ratio (WHR) are useful measures of cardiac risk. 
Despite this, most physicians do not routinely record these in clinical practice. We compared two cardiologists in the same practice- one who 
routinely measures WHR (MD-W) and one who does not (MD-noW) to determine if performing these measurements subsequently impacted upon 
Body Mass Index (BMI), WC, WHR and compliance with drug therapy.
Methods:  Chart review of sequential CAD patients first seen in 2008 and having at least a 6 month follow up visit.
Results:  70 patients were in both groups of which 75% were Caucasian. The mean age was similar (64+12 yrs) Patients were well matched for 
hypertension, diabetes, smoking, hyperlipidemia and family history of CAD, p=ns. The mean EF was 55+7 %. The average follow up time was 9.8 + 2.3 
months. The mean weight (198+40 lb), height (69+4 in) and BMI was similar in both groups (29 +5). In the MD-W group the mean WC was 39+5 
and hip circumference was 42+5 and mean WHR was 0.9+0.1. At follow-up the mean BMI remained unchanged in both groups 29+5. Similarily no 
change in WC (39+4), hip (42+5) or WHR was seen in the MD-W group. In contrast, in both groups use of pharmacotherapy increased significantly, 
p<0.05, see table.
Conclusion:Despite the prognostic value of WHR and BMI, routine office measurements of WC do not appear to modify subsequent readings while 
the same cardiologists are able to positively impact upon compliance to increased pharmacotherapy.
Improved medication compliance at follow up
Medication MD-W baseline MD-noW baseline MD-W follow up MD-noW follow up
Aspirin 76% 82% 97% 95%
statin 68% 76% 91% 85%
B blocker 56% 57% 76% 72%
ACEI/ARB 50% 52% 67% 64%
